Drawing for WE ARE BLOOD

USPTO serial 87210752

WE ARE BLOOD

Reviewed by CopyMark Law Group

Reg. 5222017Status 702Renewal
Filing date
Status date
Registration date
Jun 13, 2017
Examiner
SIRIGNANO, EMMA MARIE
Law office
TMO LAW OFFICE 113

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with WE ARE BLOOD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kirby Cronin

Kirby Cronin Ferguson Braswell Fraser Kubasta, PCP.O. BOX 164225AUSTIN, TX 78716UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
039supplying and distributing human blood products for others, namely, delivery of donated blood products to hospitals and healthcare facilities; distributing human blood products for others, namely, transportation of blood products for othersACTIVEOct 20, 2016
044Blood bank and blood bank services, namely, collection and preservation of human blood and blood components; medical services, namely, therapeutic apheresis and transfusion procedures, white blood cell and platelet depletion, therapeutic plasma exchange, red blood cell exchange; collection and preservation of human blood; community blood supply management services, namely, collection and preservation of human blood and blood bank services; medical services, namely, processing of human blood and performing therapeutic apheresis on human blood, stem cell collection and related treatments; providing a website featuring information about the importance of donating blood and blood components, how to donate blood and blood components, the best way for individuals to donate blood and blood components depending on their blood type; patient blood testing for cross-testing purposes; medical services, namely, autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant hormone refractory prostate cancer; mobile human blood collection; apheresis automated human blood collection; medical testing of blood; infectious disease testing of blood and blood component donors; therapeutic phlebotomy services; compatibility and reference testing for patient samples of blood or blood products; collection and preservation of human blood, namely, collecting autologous donations; collection and preservation of human blood, namely, mononuclear cell (MNC), granulocyte, and peripheral blood stem cell collections; collection and preservation of human blood, namely, collecting automated red cell donations; tissue baking services, namely, adult stem cell collections and banking service for individuals who wish to collect and store stem cells for future medical useACTIVEOct 20, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 13, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 27, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 27, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 27, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 18, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Jun 13, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 5, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 9, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 31, 2017COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jul 31, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 23, 2017ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jun 13, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 16, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 15, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 14, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 4, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 4, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 4, 2017EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Feb 4, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 30, 2017DOCKASSIGNED TO EXAMINER—
Oct 27, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 26, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance